3M CO Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- 3M CO payments for repurchase of common stock for the quarter ending 2026-06-30 was $994.00M, a 4.30% increase year-over-year.
- 3M CO payments for repurchase of common stock for the quarter ending 2026-03-31 was $2.00B, a 56.91% increase year-over-year.
- 3M CO payments for repurchase of common stock for the quarter ending 2025-12-31 was $552.00M, a 21.70% decline year-over-year.
- 3M CO payments for repurchase of common stock for the quarter ending 2025-09-30 was $472.00M, a 30.07% decline year-over-year.
- 3M CO payments for repurchase of common stock for fiscal 2025 was $3.25B, a 80.51% increase from fiscal 2024.
- 3M CO payments for repurchase of common stock for fiscal 2024 was $1.80B, a 5357.58% increase from fiscal 2023.
- 3M CO payments for repurchase of common stock for fiscal 2023 was $33.00M, a 97.75% decline from fiscal 2022.
- 3M CO payments for repurchase of common stock for fiscal 2022 was $1.46B, a 33.42% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $994.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $4.02B derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $2.00B 10-Q · filed 2026-04-21 | $3.98B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | $552.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $3.25B 10-K · filed 2026-02-03 |
| 2025-09-30 | $472.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $3.40B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | $953.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $3.61B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $1.27B 10-Q · filed 2026-04-21 | $3.05B derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $705.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.80B 10-K · filed 2026-02-03 |
| 2024-09-30 | $675.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $1.10B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $400.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-18 | $425.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $21.00M 10-Q · filed 2025-04-22 | $25.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $33.00M 10-K · filed 2026-02-03 |
| 2023-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | $567.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $720.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-03-31 | $29.00M 10-Q · filed 2024-04-30 | $720.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2022-12-31 | $536.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $1.46B 10-K · filed 2025-02-05 |
| 2022-09-30 | $155.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | $1.87B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $2.24B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $773.00M 10-Q · filed 2023-04-25 | $2.74B derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $938.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $2.20B 10-K · filed 2024-02-07 |
| 2021-09-30 | $527.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $1.26B derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-06-30 | $503.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $736.00M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-03-31 | $231.00M 10-Q · filed 2022-04-26 | $234.00M derived: sum of 4 quarters · filed 2023-02-08 |
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $368.00M 10-K · filed 2023-02-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | $530.00M derived: sum of 4 quarters · filed 2022-04-26 |
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $672.00M derived: sum of 4 quarters · filed 2022-04-26 |
| 2020-03-31 | $365.00M 10-Q · filed 2021-04-27 | $1.07B derived: sum of 4 quarters · filed 2022-04-26 |
| 2019-12-31 | $164.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-04-26 | $1.41B 8-K · filed 2022-04-26 |
| 2019-09-30 | $142.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $2.51B derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-06-30 | $400.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $3.43B derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-03-31 | $701.00M 10-Q · filed 2020-04-28 | $4.63B derived: sum of 4 quarters · filed 2021-02-04 |
| 2018-12-31 | $1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $4.87B 10-K · filed 2021-02-04 |
| 2018-09-30 | $1.06B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $4.11B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $1.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $3.42B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $937.00M 10-Q · filed 2019-04-26 | $2.31B derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $504.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $2.07B 10-K · filed 2020-02-06 |
| 2017-09-30 | $380.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $2.49B derived: sum of 4 quarters · filed 2019-02-07 |
| 2017-06-30 | $494.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $2.88B derived: sum of 4 quarters · filed 2019-02-07 |
| 2017-03-31 | $690.00M 10-Q · filed 2018-05-08 | $3.22B derived: sum of 4 quarters · filed 2019-02-07 |
| 2016-12-31 | $924.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $3.75B 10-K · filed 2019-02-07 |
| 2016-09-30 | $774.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $3.96B derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-06-30 | $828.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $4.71B derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-03-31 | $1.23B 10-Q · filed 2017-05-03 | $5.58B derived: sum of 4 quarters · filed 2018-05-08 |
| 2015-12-31 | $1.13B derived: 8-K 12 month − 10-Q 9 month · filed 2018-05-08 | $5.24B 8-K · filed 2018-05-08 |
| 2015-09-30 | $1.52B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $5.38B derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-06-30 | $1.70B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $5.10B derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-03-31 | $886.00M 10-Q · filed 2016-05-03 | $4.83B derived: sum of 4 quarters · filed 2017-05-04 |
| 2014-12-31 | $1.28B derived: 8-K 12 month − 10-Q 9 month · filed 2017-05-04 | $5.65B 8-K · filed 2017-05-04 |
| 2014-09-30 | $1.24B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $6.05B derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-06-30 | $1.43B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $6.35B derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-03-31 | $1.71B 10-Q · filed 2015-04-30 | $6.12B derived: sum of 4 quarters · filed 2016-05-17 |
| 2013-12-31 | $1.67B derived: 8-K 12 month − 10-Q 9 month · filed 2016-05-17 | $5.21B 8-K · filed 2016-05-17 |
| 2013-09-30 | $1.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $4.25B derived: sum of 4 quarters · filed 2015-02-12 |
| 2013-06-30 | $1.19B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $3.04B derived: sum of 4 quarters · filed 2015-02-12 |
| 2013-03-31 | $805.00M 10-Q · filed 2014-05-01 | $2.48B derived: sum of 4 quarters · filed 2015-02-12 |
| 2012-12-31 | $714.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $2.20B 10-K · filed 2015-02-12 |
| 2012-09-30 | $327.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.98B derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-06-30 | $639.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $2.51B derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-03-31 | $524.00M 10-Q · filed 2013-05-02 | $2.54B derived: sum of 4 quarters · filed 2014-05-15 |
| 2011-12-31 | $494.00M derived: 8-K 12 month − 10-Q 9 month · filed 2014-05-15 | $2.70B 8-K · filed 2014-05-15 |
| 2011-09-30 | $849.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $2.65B derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | $678.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $1.82B derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-03-31 | $680.00M 10-Q · filed 2012-05-03 | $1.51B derived: sum of 4 quarters · filed 2012-05-03 |
| 2010-12-31 | $439.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $854.00M 10-K · filed 2012-02-16 |
| 2010-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $422.00M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-06-30 | $373.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $404.00M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-03-31 | $20.00M 10-Q · filed 2011-05-05 | |
| 2009-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $17.00M 10-K · filed 2012-02-16 |
| 2009-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | |
| 2008-12-31 | $34.00M derived: 8-K 12 month − 10-Q 9 month · filed 2011-05-26 | $1.63B 8-K · filed 2011-05-26 |
| 2008-09-30 | $515.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30 | |
| 2007-12-31 | $3.24B 8-K · filed 2010-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |